Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
611
mi
from
Chicago, IL
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Childrens Memorial
611
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1148
mi
from
Baltimore, MD
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Johns Hopkins University
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1444
mi
from
Boston, MA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Dana Farber
1444
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
807
mi
from
Ann Arbor, MI
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
C.S Mott Children's Hospital
807
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
551
mi
from
Minneapolis, MN
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Childrens Hospital & Clinics of Minnesota
551
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
552
mi
from
Minneapolis, MN
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
University of Minnesota Children's Hospital
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
198
mi
from
Kansas City, MO
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Children's Mercy Hospital
198
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1290
mi
from
New York, NY
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Children's Hospital New York-Presbyterian
1290
mi
from
New York, NY
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1288
mi
from
New York, NY
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
New York University Medical Center
1288
mi
from
New York, NY
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
957
mi
from
Charlotte, NC
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Levine Children's Hospital at Carolinas Medical Center
957
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
811
mi
from
Columbus, OH
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1383
mi
from
Portland, OR
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1225
mi
from
Philadelphia, PA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Children's Hospital of Philadelphia
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
468
mi
from
Memphis, TN
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
St. Jude
468
mi
from
Memphis, TN
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
618
mi
from
Nashville, TN
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Vanderbilt Children's Hospital
618
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
348
mi
from
Ft. Worth, TX
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Cook Children's Medical Center
348
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
1410
mi
from
Seattle, WA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Seattle Children's Hospital
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Status: Enrolling
Updated:  3/12/2013
1290
mi
from
New York, NY
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Status: Enrolling
Updated: 3/12/2013
New York State Psychiatric Institute
1290
mi
from
New York, NY
Click here to add this to my saved trials
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia
Status: Enrolling
Updated:  3/14/2013
694
mi
from
New Orleans, LA
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia
Status: Enrolling
Updated: 3/14/2013
Ochsner Clinic Foundation
694
mi
from
New Orleans, LA
Click here to add this to my saved trials
Xylitol Disk Use in Adults With Dry Mouth
XyliMelts Ability to Reduce Mutans Streptococci in Adults With the Perception of Dry Mouth
Status: Enrolling
Updated:  3/27/2013
1410
mi
from
Seattle, WA
Xylitol Disk Use in Adults With Dry Mouth
XyliMelts Ability to Reduce Mutans Streptococci in Adults With the Perception of Dry Mouth
Status: Enrolling
Updated: 3/27/2013
University of Washington, School of Dentistry, Regional Clinical Dental Research Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
853
mi
from
Phoenix, AZ
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Arizona Ear Center
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
1145
mi
from
La Jolla, CA
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
California Hearing and Balance
1145
mi
from
La Jolla, CA
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
1161
mi
from
Newport Beach, CA
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Shohet Ear Associates
1161
mi
from
Newport Beach, CA
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
1127
mi
from
Washington,
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
The George Washington University- Department of Otolaryngology
1127
mi
from
Washington,
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
1110
mi
from
Tampa, FL
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Physicians Choice Hearing and Balance
1110
mi
from
Tampa, FL
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
576
mi
from
San Antonio, TX
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Ear Medical Group
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated:  5/2/2013
779
mi
from
Salt Lake City, UT
SoundBite Hearing System 24 Month Multi Site Patient Use Study
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
University Health Science Center (University of Utah Hospital)
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Effect of Nasal Hair on Nasal Obstruction
The Effect of Vibrissae on Subjective and Objective Measures of Nasal Obstruction
Status: Enrolling
Updated:  5/7/2013
515
mi
from
Rochester, MN
The Effect of Nasal Hair on Nasal Obstruction
The Effect of Vibrissae on Subjective and Objective Measures of Nasal Obstruction
Status: Enrolling
Updated: 5/7/2013
Mayo Clinic Rochester
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
611
mi
from
Chicago, IL
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
1329
mi
from
Stanford, CA
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Stanford University
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
676
mi
from
Birmingham, AL
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
1177
mi
from
Los Angeles, CA
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
University of California at Los Angeles
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
428
mi
from
Iowa City, IA
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
University of Iowa
428
mi
from
Iowa City, IA
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
808
mi
from
Ann Arbor, MI
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
1410
mi
from
Seattle, WA
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Univ of Washington
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated:  5/14/2013
413
mi
from
St Louis, MO
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Washington University
413
mi
from
St Louis, MO
Click here to add this to my saved trials
L-carnitine to Treat Fatigue Associated With Crohn's Disease
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated:  5/15/2013
1339
mi
from
San Francisco, CA
L-carnitine to Treat Fatigue Associated With Crohn's Disease
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated: 5/15/2013
UCSF Medical Center, Mt. Zion Medical Center
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
Role of Beta-Endorphin in Cancer Therapy Fatigue
Beta-Endorphin as a Mediator of Cancer Therapy-Induced Fatigue
Status: Enrolling
Updated:  5/21/2013
1443
mi
from
Boston, MA
Role of Beta-Endorphin in Cancer Therapy Fatigue
Beta-Endorphin as a Mediator of Cancer Therapy-Induced Fatigue
Status: Enrolling
Updated: 5/21/2013
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Status: Enrolling
Updated:  5/23/2013
1038
mi
from
Chapel Hill, NC
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Status: Enrolling
Updated: 5/23/2013
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Neurobehavioral Phenotypes in MPS III
Characterizing the Neurobehavioral Phenotype(s) in MPS III
Status: Enrolling
Updated:  6/5/2013
552
mi
from
Minneapolis, MN
Neurobehavioral Phenotypes in MPS III
Characterizing the Neurobehavioral Phenotype(s) in MPS III
Status: Enrolling
Updated: 6/5/2013
Univ of Minnesota
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cognitive Training for Firefighters With Tinnitus
Investigating the Impact of Cognitive Training for Firefighters With Tinnitus
Status: Enrolling
Updated:  6/10/2013
414
mi
from
Saint Louis, MO
Cognitive Training for Firefighters With Tinnitus
Investigating the Impact of Cognitive Training for Firefighters With Tinnitus
Status: Enrolling
Updated: 6/10/2013
Washington University School of Medicine
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Vitamin D3 Supplementation for Heart Failure Patients
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated:  6/18/2013
1035
mi
from
Missoula, MT
Vitamin D3 Supplementation for Heart Failure Patients
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
The International Heart Institute of Montana
1035
mi
from
Missoula, MT
Click here to add this to my saved trials
Vitamin D3 Supplementation for Heart Failure Patients
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated:  6/18/2013
1035
mi
from
Missoula, MT
Vitamin D3 Supplementation for Heart Failure Patients
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
Saint Patrick Hosptial
1035
mi
from
Missoula, MT
Click here to add this to my saved trials
Rivastigmine Study in Adolescents With Down Syndrome
A 20-Week Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of Rivastigmine in Children (Ages 10-18) With Down Syndrome
Status: Enrolling
Updated:  6/24/2013
1149
mi
from
Baltimore, MD
Rivastigmine Study in Adolescents With Down Syndrome
A 20-Week Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of Rivastigmine in Children (Ages 10-18) With Down Syndrome
Status: Enrolling
Updated: 6/24/2013
Kennedy Krieger Institute
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Pilot Study of Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Status: Enrolling
Updated:  6/26/2013
468
mi
from
Memphis, TN
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Pilot Study of Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 6/26/2013
St. Jude Children's Research Hospital
468
mi
from
Memphis, TN
Click here to add this to my saved trials
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers
Status: Enrolling
Updated:  7/4/2013
984
mi
from
Eire, PA
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers
Status: Enrolling
Updated: 7/4/2013
Penn North Centers for Advance Wound Care
984
mi
from
Eire, PA
Click here to add this to my saved trials
A Trial of Magnesium Dependent Tinnitus
A Phase III Trial of Magnesium Dependent Tinnitus
Status: Enrolling
Updated:  7/9/2013
835
mi
from
Scottsdale, AZ
A Trial of Magnesium Dependent Tinnitus
A Phase III Trial of Magnesium Dependent Tinnitus
Status: Enrolling
Updated: 7/9/2013
Mayo Clinic Arizona
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Assessment of Vitamin D Supplementation and Immune Function
Assessment of Vitamin D Supplementation and Immune Function
Status: Enrolling
Updated:  7/18/2013
1297
mi
from
Davis, CA
Assessment of Vitamin D Supplementation and Immune Function
Assessment of Vitamin D Supplementation and Immune Function
Status: Enrolling
Updated: 7/18/2013
Western Human Nutrition Center, University of California Davis
1297
mi
from
Davis, CA
Click here to add this to my saved trials